Compare Exenatide (evidence A) and Lixisenatide (evidence A) on mechanism, clinical status, safety, and dosing.
Exenatide is a 39-amino-acid GLP-1 receptor agonist (MW ~4186.6 g/mol) originally derived from exendin-4, a peptide found in the saliva of the Gila monster…
Lixisenatide is a once-daily GLP-1 receptor agonist (MW ~4858.5 g/mol) based on the exendin-4 scaffold, with a modified C-terminal tail containing six lysine…
Full profiles: Exenatide, Lixisenatide.